A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer

Clinical trial NCT02670746 · TERMINATED

Trial details

NCT number: NCT02670746
Sponsor: Celgene
Status: TERMINATED
Study type: OBSERVATIONAL

Pancreatic Neoplasms

Start date: 2015-10-01
Primary completion: 2017-11-28
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.